{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:54:57Z","timestamp":1781074497013,"version":"3.54.1"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35 GM118097, R35 GM118337, T32 GM065085"],"award-info":[{"award-number":["R35 GM118097, R35 GM118337, T32 GM065085"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Sepsis remains a major source of morbidity and mortality in neonates, and characterization of immune regulation in the neonatal septic response remains limited. HVEM is a checkpoint regulator which can both stimulate or inhibit immune responses and demonstrates altered expression after sepsis. We hypothesized that signaling via HVEM would be essential for the neonatal response to sepsis, and that therefore blockade of this pathway would improve survival to septic challenge.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>To explore this, neonatal mice were treated with cecal slurry (CS), CS with Anti-HVEM antibody (CS-Ab) or CS with isotype (CS-IT) and followed for 7-day survival. Mice from all treatment groups had thymus, lung, kidney and peritoneal fluid harvested, weighed, and stained for histologic evaluation, and changes in cardiac function were assessed with echocardiography.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Mortality was significantly higher for CS-Ab mice (72.2%) than for CS-IT mice (22.2%). CS resulted in dysregulated alveolar remodeling, but CS-Ab lungs demonstrated significantly less dysfunctional alveolar remodeling than CS alone (MCL 121.0 CS vs. 87.6 CS-Ab), as well as increased renal tubular vacuolization. No morphologic differences in alveolar septation or thymic karyorrhexis were found between CS-Ab and CS-IT. CS-Ab pups exhibited a marked decrease in heart rate (390.3 Sh vs. 342.1 CS-Ab), stroke volume (13.08 CS-IT vs. 8.83 CS-Ab) and ultimately cardiac output (4.90 Sh vs. 3.02 CS-Ab) as well as a significant increase in ejection fraction (73.74 Sh vs. 83.75 CS-Ab) and cardiac strain (40.74 Sh vs. 51.16 CS-Ab) as compared to CS-IT or Sham animals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>While receptor ligation of aspects of HVEM signaling, via antibody blockade, appears to mitigate aspects of lung injury and thymic involution, stimulatory signaling via HVEM still seems to be necessary for vascular and hemodynamic resilience and overall neonatal mouse survival in response to this experimental polymicrobial septic insult.  This dissonance in the activity of anti-HVEM neutralizing antibody in neonatal animals speaks to the differences in how septic cardiac dysfunction should be considered and approached in the neonatal population.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1365174","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T04:23:39Z","timestamp":1715055819000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Herpes virus entry mediator signaling blockade produces mortality in neonatal sepsis through induced cardiac dysfunction"],"prefix":"10.3389","volume":"15","author":[{"given":"Michelle E.","family":"Wakeley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi-Liza","family":"Denning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique E.","family":"De Paepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Shiang","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Ayala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,7]]},"reference":[{"key":"B1","article-title":"Deaths: Preliminary Data for 2010","volume-title":"National Vital Statistics Report","author":"Murphy","year":"2012"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"Jama"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nri2402","article-title":"Harmful molecular mechanisms in sepsis","volume":"8","author":"Rittirsch","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000003685","article-title":"Immune checkpoint inhibition in sepsis: A phase 1b randomized, placebo-controlled, single ascending dose study of antiprogrammed cell death-ligand 1 (BMS-936559)","volume":"47","author":"Hotchkiss","year":"2019","journal-title":"Crit Care Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2017.00014","article-title":"Immunological defects in neonatal sepsis and potential therapeutic approaches","volume":"5","author":"Raymond","year":"2017","journal-title":"Front Pediatrics"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2010.11928649","article-title":"Changing epidemiology of trauma deaths leads to a bimodal distribution","volume":"23","author":"Gunst","year":"2010","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40779-016-0104-3","article-title":"Early prevention of trauma-related infection\/sepsis","volume":"3","author":"Ma","year":"2016","journal-title":"Mil Med Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00595-010-4323-z","article-title":"Immunosuppression following surgical and traumatic injury","volume":"40","author":"Kimura","year":"2010","journal-title":"Surg Today"},{"key":"B9","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/cc6091","article-title":"Bench-to-bedside review: Developmental influences on the mechanisms, treatment and outcomes of cardiovascular dysfunction in neonatal versus adult sepsis","volume":"11","author":"Luce","year":"2007","journal-title":"Crit Care"},{"key":"B10","doi-asserted-by":"publisher","first-page":"R150","DOI":"10.1186\/cc9218","article-title":"A systematic review of randomized controlled trials exploring the effect of immunomodulative interventions on infection, organ failure, and mortality in trauma patients","volume":"14","author":"Spruijt","year":"2010","journal-title":"Crit Care"},{"key":"B11","doi-asserted-by":"publisher","first-page":"8825","DOI":"10.1038\/ncomms9825","article-title":"Rescue of neonatal cardiac dysfunction in mice by administration of cardiac progenitor cells","volume":"6","author":"Liu","year":"2015","journal-title":"utero Nat Commun"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1126\/science.169.3950.1042","article-title":"A theory of self-nonself discrimination","volume":"169","author":"Bretscher","year":"1970","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/icb.1975.3","article-title":"A new analysis of allogeneic interactions","volume":"53","author":"Lafferty","year":"1975","journal-title":"Aust J Exp Biol Med Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.8.4911-4927.2003","article-title":"Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment","volume":"77","author":"Wherry","year":"2003","journal-title":"J Virol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.2MIR0917-377R","article-title":"A novel role for coinhibitory receptors\/checkpoint proteins in the immunopathology of sepsis","volume":"2","author":"Fallon","year":"2018","journal-title":"J Leukoc Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/imm.13001","article-title":"VSIG-3 as a ligand of VISTA inhibits human T-cell function","volume":"156","author":"Wang","year":"2019","journal-title":"Immunology"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2009.00783.x","article-title":"The CD160, BTLA, LIGHT\/HVEM pathway: a bidirectional switch regulating T-cell activation","volume":"229","author":"Cai","year":"2009","journal-title":"Immunol Rev"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81363-X","article-title":"Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF\/NGF receptor family","volume":"87","author":"Montgomery","year":"1996","journal-title":"Cell"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.22.14029","article-title":"Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kappaB and AP-1","volume":"272","author":"Marsters","year":"1997","journal-title":"J Biol Chem"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/nri1917","article-title":"Balancing co-stimulation and inhibition with BTLA and HVEM","volume":"6","author":"Murphy","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2011.08.008","article-title":"TNF Superfamily Networks: bidirectional and interference pathways of the herpesvirus entry mediator (TNFSF14)","volume":"23","author":"Ware","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1172\/JCI22982","article-title":"The role of herpesvirus entry mediator as a negative regulator of T cell-mediated responses","volume":"115","author":"Wang","year":"2005","journal-title":"J Clin Invest"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902490","article-title":"T cell intrinsic heterodimeric complexes between HVEM and BTLA determine receptivity to the surrounding microenvironment","volume":"183","author":"Cheung","year":"2009","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1189\/jlb.1211641","article-title":"BTLA expression contributes to septic morbidity and mortality by inducing innate inflammatory cell dysfunction","volume":"92","author":"Shubin","year":"2012","journal-title":"J Leukoc Biol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"R276","DOI":"10.1186\/cc13131","article-title":"B and T lymphocyte attenuator expression on CD4+ T-cells associates with sepsis and subsequent infections in ICU patients","volume":"17","author":"Shubin","year":"2013","journal-title":"Crit Care"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nature11242","article-title":"HVEM signalling at mucosal barriers provides host defence against pathogenic bacteria","volume":"488","author":"Shui","year":"2012","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302252","article-title":"Identification of B7-H1 as a novel mediator of the innate immune\/proinflammatory response as well as a possible myeloid cell prognostic biomarker in sepsis","volume":"192","author":"Huang","year":"2014","journal-title":"J Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0809422106","article-title":"PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis","volume":"106","author":"Huang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2016.11.008","article-title":"Improved survival after induction of sepsis by cecal slurry in PD-1 knockout murine neonates","volume":"161","author":"Young","year":"2017","journal-title":"Surgery"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000001174","article-title":"Herpes virus entry mediator (HVEM) expression promotes inflammation\/ organ injury in response to experimental indirect-acute lung injury","volume":"51","author":"Cheng","year":"2019","journal-title":"Shock"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/shk.0b013e3180556d09","article-title":"Increased mortality and altered immunity in neonatal sepsis produced by generalized peritonitis","volume":"28","author":"Wynn","year":"2007","journal-title":"Shock"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000001212","article-title":"Minimum quality threshold in pre-clinical sepsis studies (MQTiPSS): an international expert consensus initiative for improvement of animal modeling in sepsis","volume":"50","author":"Osuchowski","year":"2018","journal-title":"Shock"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-09-047332","article-title":"Selective targeting of the LIGHT-HVEM costimulatory system for the treatment of graft-versus-host disease","volume":"109","author":"Xu","year":"2007","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.2000.279.5.L967","article-title":"Fas ligand expression coincides with alveolar cell apoptosis in late-gestation fetal lung development","volume":"279","author":"De Paepe","year":"2000","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/SHK.0000000000000073","article-title":"Early murine polymicrobial sepsis predominantly causes renal injury","volume":"41","author":"Craciun","year":"2014","journal-title":"Shock"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.346","article-title":"Pre-existing renal disease promotes sepsis-induced acute kidney injury and worsens outcome","volume":"74","author":"Doi","year":"2008","journal-title":"Kidney Int"},{"key":"B37","doi-asserted-by":"publisher","first-page":"593","DOI":"10.2147\/CIA","article-title":"Acute kidney injury and inflammatory response of sepsis following cecal ligation and puncture in d-galactose-induced aging rats","volume":"12","author":"Liu","year":"2017","journal-title":"Clin Interv Aging"},{"key":"B38","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s10020-020-00243-6","article-title":"Targeting the eCIRP\/TREM-1 interaction with a small molecule inhibitor improves cardiac dysfunction in neonatal sepsis","volume":"26","author":"Denning","year":"2020","journal-title":"Mol Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"H733","DOI":"10.1152\/ajpheart.00339.2017","article-title":"Guidelines for measuring cardiac physiology in mice","volume":"314","author":"Lindsey","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012260","article-title":"Myocardial strain and cardiac output are preferable measurements for cardiac dysfunction and can predict mortality in septic mice","volume":"8","author":"Hoffman","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1176602","article-title":"Lymphocyte HVEM\/BTLA co-expression after critical illness demonstrates severity indiscriminate upregulation, impacting critical illness-induced immunosuppression","volume":"10","author":"Wakeley","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01469","article-title":"Program cell death receptor-1-mediated invariant natural killer T-cell control of peritoneal macrophage modulates survival in neonatal sepsis","volume":"8","author":"Fallon","year":"2017","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.molimm.2014.06.013","article-title":"Herpesvirus entry mediator (HVEM) attenuates signals mediated by the lymphotoxin beta receptor (LTbetaR) in human cells stimulated by the shared ligand LIGHT","volume":"62","author":"Bechill","year":"2014","journal-title":"Mol Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s11897-014-0247-z","article-title":"Pathophysiology of sepsis-related cardiac dysfunction: driven by inflammation, energy mismanagement, or both","volume":"12","author":"Drosatos","year":"2015","journal-title":"Curr Heart Fail Rep"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1097\/00024382-199504000-00003","article-title":"The induction of accelerated thymic programmed cell death during polymicrobial sepsis: control by corticosteroids but not tumor necrosis factor","volume":"3","author":"Ayala","year":"1995","journal-title":"Shock"},{"key":"B46","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40779-016-0099-9","article-title":"Pathophysiology of sepsis-induced myocardial dysfunction","volume":"3","author":"Lv","year":"2016","journal-title":"Mil Med Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"37277","DOI":"10.1038\/srep37277","article-title":"The synthetic antimicrobial peptide 19-2.5 attenuates septic cardiomyopathy and prevents down-regulation of SERCA2 in polymicrobial sepsis","volume":"6","author":"Martin","year":"2016","journal-title":"Sci Rep"},{"key":"B48","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ccc.2019.08.006","article-title":"Check point inhibitors and their role in immunosuppression in sepsis","volume":"36","author":"Wakeley","year":"2020","journal-title":"Crit Care Clin"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2015.04.027","article-title":"Development of immunity in early life","author":"Goenka","year":"2015","journal-title":"J Infect"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1365174\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T04:23:46Z","timestamp":1715055826000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1365174\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,7]]},"references-count":49,"alternative-id":["10.3389\/fimmu.2024.1365174"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1365174","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,7]]},"article-number":"1365174"}}